Abstract
The present invention provides a keratoprosthesis assembly comprising a central optical core; and a peripheral skirt comprising at least one porous biocompatible layer and methods of using it in keratoprosthesis procedures.
Claims
1. A keratoprosthesis comprising: (a) a transparent central optical core; and (b) an annular peripheral skirt attached to and substantially surrounding a Perimeter of said central optical core, said annular peripheral skirt comprising an anterior conjunctiva-contacting surface configured to contact a posterior surface of the conjunctiva of the patient's eye, a posterior sclera-contacting surface configured to contact an anterior surface of the sclera of the patient's eye, said peripheral skirt comprising at least one porous biocompatible layer having pore size of at least 2 m; wherein said central optical core has a diameter of at least 3 mm and further comprises an extended portion extending axially below a surface formed by the central optical core and annular peripheral skirt, said extended portion sized and configured for anchoring said central optical core in place into a trephined space of a central cornea of a patient's eye; and wherein said peripheral skirt has a width of at least 3 mm and a thickness ranging from about 100 microns to about 2000 microns, wherein the peripheral skirt is sized and configured so that it can be placed under the conjunctiva and above sclera of the eye, wherein the width of the peripheral skirt extends from attachment to perimeter of central optical core to an outer edge of the peripheral skirt.
2. The keratoprosthesis according to claim 1, wherein said at least one porous biocompatible layer has a pore size of 2 pm to 100 pm.
3. The keratoprosthesis according to claim 1, wherein said at least one porous biocompatible layer is a polymeric layer.
4. The keratoprosthesis according to claim 1, wherein said at least one porous biocompatible layer is a nonwoven fabric.
5. The keratoprosthesis according to claim 1, wherein said at least one porous biocompatible layer comprises nanofibers.
6. The keratoprosthesis according to claim 1, wherein said at least one porous biocompatible layer is formed by electrospinning process.
7. The keratoprosthesis according to claim 1, wherein said at least one porous biocompatible layer is selected from the group consisting of poly(DTE carbonate) polycaprolactone (PCL), polylactic acid (PLA), poly-L-lactic acid (PLLA), Poly(DL-lactide-co-caprolactone, Poly(ethylene-co-vinyl acetate) vinyl acetate, Poly(methyl methacrylate), Poly(propylene carbonate), Poly(vinylidene fluoride), Polyacrylonitrile, Polycaprolactone, Polycarbomethylsilane, Polylactic acid, Polystyrene, Polyvinylpyrrolidone, poly vinyl alcohol (PVA), polyethylene oxide (PEO), polyurethane, polyvinyl chloride (PVC), hyaluronic acid (HA), chitosan, alginate, polyhydroxybuyrate and its copolymers, Nylon 11, Cellulose acetate, hydroxyappetite, poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid), poly(DL-lactide), polycaprolactone, and poly(L-lactide) or any combination thereof.
8. The keratoprosthesis according to of claim 1, wherein the central optical core has a diameter ranging from about 3 to 15 mm.
9. The keratoprosthesis according to of claim 1, wherein the central optical core has a thickness ranging from about 500 micrometers to 3000 micrometers.
10. The keratoprosthesis according to of claim 1, wherein the peripheral skirt further comprises a biomolecule or an antibiotic agent.
11. The keratoprosthesis according to of claim 1, wherein the peripheral skirt further comprises a biomolecule wherein the biomolecule is selected from the group consisting of a protein, type I collagen, fibronectin, or TGF-beta 2, heparin, growth factors, antibodies, antimetabolites, chemotherapeutic agents, and any combinations thereof.
12. The keratoprosthesis according to of claim 1, wherein the peripheral skirt has a width of between 3 to 9 mm.
13. The keratoprosthesis according to of claim 1, wherein the peripheral skirt has a width ranging from about 4 to about 6 mm.
14. The keratoprosthesis according to of claim 1, wherein said optical core and peripheral skirt are mechanically attached to each other.
15. The keratoprosthesis according to of claim 1, wherein said optical core and peripheral skirt are chemically attached to each other.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) In order to better understand the subject matter that is disclosed herein and to exemplify how it may be carried out in practice, embodiments will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:
(2) FIG. 1 provides a schematic view of an exemplary keratoprosthesis of the invention and an eye to be implanted.
(3) FIG. 2 provides a schematic view of an exemplary keratoprosthesis of the invention.
(4) FIG. 3 is a cross section view of an exemplary keratoprosthesis of the invention implanted into the eye.
(5) FIGS. 4A-4B is a cross section view of an exemplary keratoprosthesis of the invention. FIG. 4A shows an exemplary central optical core part of the keratoprosthesis and FIG. 4B shows an exemplary central optical core with the peripheral skirt.
(6) FIG. 5 is a cross section view of an exemplary keratoprosthesis of the invention.
(7) FIGS. 6A-6G provides the steps for the keratoprosthesis procedure using an artificial cornea on the invention showing a single stage, 30 minute procedure that is significantly simpler than any existing solution.
DETAILED DESCRIPTION OF EMBODIMENTS
(8) FIG. 1 shows an embodiment of a keratoprosthesis of the invention 100, consisting of a transparent central optical core 101 and a peripheral skirt 103. The central optical core 101 is extended towards the anterior chamber of the eye with an extension 102 suitable for anchoring said central core in place into the trephined space 104 of the central cornea 105.
(9) FIG. 2 shows an embodiment of a keratoprosthesis of the invention 200, consisting of a transparent central optical core 201 and a peripheral skirt 202. The central optical core 201 is extended towards the anterior chamber of the eye with an extension 203 suitable for anchoring said central core in place into the trephined space of the central cornea.
(10) FIG. 3 shows an embodiment of a keratoprosthesis of the invention 300, placed on the eye of a subject wherein said keratoprosthesis consisting of a transparent central optical core 301 and a peripheral skirt 303. The central optical core 301 is extended towards the anterior chamber of the eye with an extension 302 suitable for anchoring said central core in place into the trephined space 304 (not shown) of the central cornea 305. It is noted that the peripheral skirt 303 when placed on the eye after trephination of the catral cornea extends anteriorly towards the spiral of tillux 306.
(11) FIGS. 4A-4B is a cross section view of an exemplary keratoprosthesis of the invention. FIG. 4A shows an exemplary central optical core part 400 of the keratoprosthesis. The central optical core 400 is formed of PMMA (approved material for eye implants, similar to the material using in contact lenses) providing a large diameter optical zone. The central core is extended from the concave plane of the central core 401 to form at least one groove 402 shown in FIG. 4B (of multiple optional shapes supporting laser and manual trephination) which enables the implant of the invention to snap and fit into a hole cut in the existing cornea for immediate water-tightness. The at least one groove 402 holds the remaining cornea margins (see also in FIG. 5). The at least one groove 402 also enables thorough clinical exam and inter-ocular access. The central optical core further optionally comprises at least one hole/hollow arches 403 and 405 ensuring optical core-to-skirt (PMMA-to-nanofiber) stability and retention once implanted into human tissue.
(12) FIG. 4B shows an exemplary central optical core (400) with the peripheral skirt (404). The skirt is positioned subconjunctively and integrates with the conjunctiva, including through at least one hole and arcs 403 cut into the optical element. The skirt is made from electrospun polymer which is biocompatible and stimulates cell growth. The biocompatible porous fibrous material of the Scaffold for cellular proliferation enabling biointegration.
(13) FIG. 5 is a cross section view of an exemplary keratoprosthesis of the invention 500 implanted into cornea after removal of the diseased cornea. The optical central core 501 is placed above anterial chamber (not shown) and is held tightly into position due to two structural elements including an extension of the optical core 502 and an extension of the exterior optical core 503 forming a groove 504 that holds the remaining margins of the lessered cornea. This at least one groove provides stable positioning of the artificial cornea snapped in and fitting into a hole cut in the existing cornea for immediate water-tightness. The central core also comprises at least one hole and/or hollow arches 505 and 506 ensuring core (501) to skirt (507) (PMMA-to-nanofiber) strength and retention once infiltrated with human tissue. 507 is a representative position of the peripheral skirt of the keratoprosthesis of the invention which is formed of nanofiber electrospun layer enabling cell tissue to grow and assimilate device into the conjunctiva.
(14) FIGS. 6A-6G provides the steps for the keratoprosthesis procedure using an artificial cornea on the invention showing a single stage, 30 minute procedure that is significantly simpler than any existing solution. The process is performed for example using the following steps: FIG. 6A the eye is filled with viscoelastic material FIG. 6B a peritomy of 360 degrees is made elevating both conjunctive and tenon FIG. 6C trephination of the central cornea is carried out FIG. 6D the optical zone is inserted into the tephinated space FIG. 6E the biointegrating skirt is laid on the bare sclera and optionally sutured to it FIG. 6F the tenon and conjunctiva is put back in place over the porous skirt and optionally sutured tight FIG. 6G viscoelastic is replaced with BSS (balanced saline solution)
